ORIC

Oric Pharmaceuticals, Inc.

10.95 USD
-0.04 (-0.36%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Oric Pharmaceuticals, Inc. stock is up 47.18% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 July’s closed higher than June. 100% of analysts rate it a buy.

About Oric Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. discovers and develops therapies for treatment of cancers. Its product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company was incorporated in 2014 and is headquartered in South San Francisco, California.